Loading data
DCGONasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 322.2 m USD | 616.56 m USD | 624.29 m USD | 440.52 m USD | 318.72 m USD |
| Cost of revenue | — | — | — | 523.95 m USD | 451.7 m USD |
| Research and development expense | 13.56 m USD | 11.59 m USD | 10.86 m USD | 5.38 m USD | 3.32 m USD |
| Operating profit | -178.03 m USD | 28.69 m USD | 15.05 m USD | 21.83 m USD | 15.36 m USD |
| Profit before tax | -187.5 m USD | 27.75 m USD | 16.29 m USD | 22.78 m USD | 19.8 m USD |
| Income tax expense | 8.87 m USD | 14.39 m USD | 6.24 m USD | -7.96 m USD | 615.7 k USD |
| Net income (reported basis) | -196.37 m USD | 13.36 m USD | 10.05 m USD | 30.74 m USD | 19.18 m USD |
| Net income attributable to common shareholders | -182.4 m USD | 19.99 m USD | 6.86 m USD | 34.58 m USD | 23.74 m USD |
| Basic earnings per share | -1.84 USD/share | 0.2 USD/share | 0.07 USD/share | 0.34 USD/share | 0.3 USD/share |
| Diluted earnings per share | -1.84 USD/share | 0.18 USD/share | 0.06 USD/share | 0.34 USD/share | 0.25 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.